|
Joe (and JO Jo),
Thank you for the question and your update. Lapatinib is getting alot of attention on the east coast here through the Boston Globe article. But I wonder about some of the other clinical trials noted on the NIH web site; ie, "combined monoclonal antibodies trastuzumab and pertuzumab", and "WBR with supplemental Oxygen, with or without concurrent RSR13", are either of you aware of these other trials and have you heard which ones seem to be the most promising?
Love Kim from CT
|